Overview
Creatine phosphokinase (CPK), also known as creatine kinase (CK), is an important enzyme protein found predominantly in the brain, heart, and skeletal muscles. It plays a central role in cellular energy metabolism by catalyzing the reversible conversion of creatine and phosphocreatine, a reaction essential for ATP generation.
When muscle tissue is damaged, Creatine phosphokinase leaks into the bloodstream, making it a valuable biochemical marker for detecting muscle and tissue injury. CPK exists in three isoenzyme forms, which help identify the source of tissue damage:
- CPK-BB (CPK-1): Mainly found in the brain and lungs
- CPK-MB (CPK-2): Primarily associated with cardiac muscle
- CPK-MM (CPK-3): Predominantly found in skeletal muscle
Symptoms
Abnormal CPK levels are not associated with specific symptoms themselves but reflect underlying tissue damage. Elevated CPK levels are commonly seen in conditions presenting with muscle pain, weakness, fatigue, chest pain, seizures, trauma, or neurological injury.
Patients with significant muscle breakdown may present with severe muscle pain, weakness, dark urine, or complications related to rhabdomyolysis. Cardiac involvement may be associated with chest discomfort, while neurological causes may present with seizures or altered consciousness.
Causes
Creatine phosphokinase levels increase when there is damage to muscle, heart, or brain tissue. Common causes of elevated CPK include:
- Rhabdomyolysis
- Myocardial infarction and myocarditis
- Muscular dystrophies and myopathies
- Trauma, electric shock, or convulsions
- Seizures, brain injury, or brain tumors
- Pulmonary infarction
- High muscle mass or intense physical exertion
Decreased Creatine phosphokinase levels may be observed in:
- Low muscle mass
- Severe dermatomyositis or polymyositis
- Alcoholic liver disease
- Early pregnancy (around 20 weeks)
- Rheumatoid arthritis
Risk Factors
Individuals at increased risk for abnormal Creatine phosphokinase levels include patients with cardiac disease, neuromuscular disorders, muscle trauma, inflammatory myopathies, renal disease, and those exposed to certain drugs.
Patients receiving statin therapy require Creatine phosphokinase monitoring due to the risk of drug-induced muscle injury. CPK levels may also rise following surgery, malignant hyperthermia, or postoperative infections. Neuromuscular conditions such as Guillain–Barré syndrome are also associated with altered CPK levels.
Prevention and Diagnostic Approach
CPK testing is widely used in clinical practice for evaluating muscle and cardiac injury. Although CPK was historically used to diagnose myocardial infarction—rising within 4-6 hours, peaking at 18-24 hours, and returning to normal within 48–72 hours- troponin is now considered more specific for cardiac damage.
Indications for CPK testing include:
- Evaluation of chest pain
- Assessment of muscle injury (trauma, dystrophy, inflammatory myopathy)
- Detection of dermatomyositis and polymyositis
- Diagnosis and monitoring of rhabdomyolysis
- Monitoring statin therapy
- Evaluation of malignant hyperthermia and neuromuscular disorders
Sample collection:
No special patient preparation is required. A 3.0 mL blood sample is collected in a plain red-capped tube. Serum should be separated as early as possible and sent to the laboratory.
Methods of estimation include:
- Enzymatic methods
- Enzyme-linked immunosorbent assay (ELISA)
- Chemiluminescent immunoassay (CLIA)
- Point-of-care rapid testing kits
- Electrophoresis to differentiate CPK-MM, CPK-MB, and CPK-BB
Reference ranges vary by age and sex, with adult values generally lower than pediatric ranges.
The CK-MB Relative Index (RI) is used to distinguish cardiac from skeletal muscle injury:
- >5–6%: Suggestive of myocardial damage
- <3%: Suggestive of skeletal muscle damage
- 3–5%: Equivocal, requiring further clinical correlation
Clinical Significance
CPK is a sensitive but non-specific marker of muscle injury. Total CPK reflects overall muscle damage, while isoenzyme analysis improves diagnostic accuracy. However, CPK levels are influenced by physiological factors such as age, sex, muscle mass, and physical activity.
Elevated CPK alone cannot determine the exact cause of tissue damage and must always be interpreted alongside clinical findings and other investigations. Awareness of its limitations is essential to avoid misdiagnosis.
